Numerous studies have proposed biomarkers based on magnetic resonance imaging (MRI) to detect and predict the risk of evolution toward Alzheimer's disease (AD). While anatomical MRI captures structural alterations, studies demonstrated the ability of diffusion MRI to capture microstructural modifications at an earlier stage. Several methods have focused on hippocampus structure to detect AD. To date, the patch-based grading framework provides the best biomarker based on the hippocampus. However, this structure is complex since the hippocampus is divided into several heterogeneous subfields not equally impacted by AD. Former in-vivo imaging studies only investigated structural alterations of these subfields using volumetric measurements and microstructural modifications with mean diffusivity measurements. The aim of our work is to study the efficiency of hippocampal subfields compared to the whole hippocampus structure with a multimodal patch-based framework that enables to capture subtler structural and microstructural alterations. To this end, we analyze the significance of the different hippocampal subfields for AD diagnosis and prognosis with volumetric, diffusivity measurements and a novel multimodal patch-based grading framework that combines structural and diffusion MRI. The experiments conducted in this work showed that the whole hippocampus provides the most discriminant biomarkers for advanced AD detection while biomarkers applied into subiculum obtain the best results for AD prediction, improving by 2% the accuracy compared to the whole hippocampus.
Introduction
Alzheimer's disease (AD) is an irreversible neurodegenerative process leading to mental dysfunctions. Subjects presenting Mild Cognitive Impairment (MCI) have higher risk to develop AD 1 . To study the preclinical phase of the disease, the Alzheimer's disease neuroimaging initiative (ADNI) was set up based on two MCI definitions: early MCI (eMCI) and late MCI (lMCI). eMCI represents subjects with cognitive impairment milder than lMCI which is composed of amnesic MCI 2 . Such clinical symptoms caused by changes like synaptic and neuronal losses that lead to structural and micro-structural alterations. Neuroimaging studies performed on AD subjects revealed that brain structure alterations are advanced when diagnosis is established and emphasized the need to study the early stages of the disease.
The improvement of medical imaging techniques such as magnetic resonance imaging (MRI) enabled the development of efficient biomarkers detecting alterations caused by AD 3 . Over the past years, many methods have been proposed to perform automatic detection of alterations associated with AD. First, studies proposed methods based on specific regions of interest (ROI) capturing alterations at an anatomical scale. Among structures impacted by AD, previous investigations focused on hippocampus (HIPP) [4] [5] [6] , entorhinal cortex (EC) [7] [8] [9] , parahippocampal gyrus, amygdala 10 or parietal lobe 11, 12 . Alterations on each subject. ADNI-2 provides T1-weighted (T1w) MRI and DTI scans for 54 CN, 79 eMCI, 39 lMCI and 47 AD subjects. Only patients whose have T1w and DTI were selected in our work. Hence, in this work we used 52 CN, 99 MCI composed of 65 eMCI, 34 lMCI and 38 AD instead of the whole initial ADNI-2 dataset. Table 1 shows the distribution of the data for each group. The s-MRI and d-MRI scans used for all considered subjects in this study were acquired with the same protocol (https://adni.loni.usc.edu/wp-content/uploads/2010/05/ADNI2_GE_3T_22.0_T2.pdf). T1w MRI acquisition protocol had been done with the 3D accelerated sagittal IR-SPGR, according to the ADNI protocol 60 . The d-MRI were composed of 46 separate angles, 5 T2-weighted images with no diffusion sensitization (b0 images) and 41 directions (b=1000s/mm 2 ). The d-MRI protocol was chosen to optimize the signal-to-noise ratio in a fixed scan time 61 . The native resolution of s-MRI and d-MRI was set to 1mm 3 and 2mm 3 , respectively. 
MRI processing
T1w images were processed using the volBrain system 62 (http://volbrain.upv.es). This system is based on an advanced pipeline providing automatic segmentation of different brain structures from T1w MRI. The preprocessing is based on: (a) a denoising step with an adaptive non-local mean filter 63 , (b) an affine registration in the MNI space 64 , (c) a correction of the image inhomogeneities 65 and (d) an intensity normalization. Afterwards, segmentation of hippocampal subfields was performed with HIPS 66 based on a combination of non-linear registration and patch-based label fusion 67 . This method uses a training library based on a dataset composed of high resolution T1w images manually labeled according to the protocol proposed by Winterburn et al. (2013) 35 . To perform the segmentation, the ADNI images are up-sampled with a local adaptive super resolution method to fit in the training image resolution 68 . The method provides automatic segmentation of hippocampal subfields gathered into 5 labels: Subiculum, CA1SP, CA1SR-L-M, CA2-3 and CA4/DG (see Figure 1) . Finally, an estimation of the total intra-cranial volume is performed 69 .
DTI processing
The preprocessing of the diffusion weighted images is based on: (a) a denoising with a LPCA filter 70 , (b) a correction of the head motion using an affine registration and (c) an affine and a non-rigid registration to the T1w MRI in the MNI space 64 . Afterwards, a diffusion tensor model 71 is fitted at each voxel using Dipy library 72 . To analyze microstructural modifications, the MD is estimated within each hippocampal subfield and the whole HIPP structure with the segmentation described in the previous section. MD is defined as
where λ 1 , λ 2 , λ 3 are the three eigenvalues of the fitted tensor. Finally, a quality control was proceeded to exclude data presenting miss-segmentation or miss-registration after image preprocessing step.
Methods
Patch-based grading Patch-based grading was firstly proposed for s-MRI 9 . The main idea of this exemplar-based method is to use the capability of patch-based techniques to capture subtle signal modifications related to anatomical degradations caused by AD. To date, PBG methods demonstrate state-of-the-art performances to detect the earliest stage of AD 73 . To determine the pathological status of the subject under study, PBG method estimates at each voxel the state of cerebral tissues by a similarity measurement. This measurement is performed between the anatomical pattern of the subject under study and those extracted from two training populations, one healthy and another one unhealthy.
First, a training library T composed of two datasets of images is built: one with images from CN subjects and the other one from AD patients. Next, for each voxel x i of the region of interest in the considered subject x, PBG method produces a weak classifier denoted g x i . This weak classifier provides a surrogate of the pathological grading at the considered position. The weak classifier is computed using a measurement of the similarity between the patch P x i surrounding the voxel x i belonging to the image under study and a set K x i of the closest patches extracted from the library T . The most similar patches are found using an approximative nearest neighbor method 74 . The grading value g x i at x i is defined as:
where P t j is the patch surrounding the voxel j belonging to the training template t ∈ T . w(x i ,t j ) is the weight assigned to the pathological status p t of the training image t. We estimate w such as:
where h = min ||P x i − P t j || 2 2 + ε and ε → 0. The pathological status p t is set to −1 for patches extracted from AD patient and to 1 for patches extracted from CN subject. Therefore, PBG method provides at each voxel a score representing an estimation of the alterations caused by AD. Consequently, cerebral tissues strongly altered by AD have grading values close to −1 contrary to healthy one with scores close to 1.
Multimodal patch-based grading fusion
Patch-based method presented in the previous section was firstly designed to capture structural alterations in T1w MRI. Recently, we proposed to extent this method to DTI modality in order to detect microstructural modifications 57 . We showed the efficiency of MD grading to improve the classification of the early stages of AD.
In this study, we propose a new framework to perform multimodal patch-based grading (MPBG). To this end, we developed adaptive fusion of grading maps derived from different modalities (see example of grading maps on Fig. 2 ). As shown in the following, this fusion provides more robust and accurate biomarkers compared to monomodal PBG biomarkers.
First, as in previous section, for each modality a training library of CN and AD subjects is built. Next, at each voxel within the ROI of the considered subject and for each modality, a set K of most similar patches is extracted. This step provides one set K of patches per modality m ∈ M, where M corresponds to the set of the different modalities provided. Nevertheless, at each voxel the quality of the grading estimation is not the same for all the modalities. Therefore, the degree of confidence is estimated with the function α defined as:
that reflects the confidence of the grading value g x i for the modality m at the voxel x i . This confidence measure is derived from multi-feature fusion 75 . Thus, each modality provides a weak classifier at each voxel that is weighted with its degree of
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confidence α ( x i,m ). The multimodal grading, denoted g x i , is given by:
In other words, the weight w and K x i,m are estimated independently for each modality and combined afterwards. Therefore, the proposed combination framework is spatially adaptive and takes advantage of having access to a local degree of confidence α x i,m for each modality m. Basically, when the set of patches found for a modality in the training library is composed of good candidates (i.e., patches very similar to the patch from the subject under study), our confidence α x i,m in the grading estimation for this modality is high. At the end, this modality will have a high weight in the mixing procedure described in (4). 
Features estimation
Features were estimated in each hippocampal subfield and over the whole hippocampus as the union of all hippocampal subfields masks. To reduce the inter-individual variability, all volumes are normalized by the total intra-cranial volume 76 . Afterwards, we aggregate local weak classifiers of the grading map into a single feature for each considered structure (i.e., hippocampal subfields and whole HIPP) by averaging them. Therefore, patch-based grading features are computed by an unweighted vote of the weak classifiers using the segmentation masks (see Fig. 3 ). Finally, to prevent the bias introduced as the structure alterations due to aging, all the features (i.e., volume, mean of MD and MPBG) are age corrected with a linear regression based on the CN group 77 .
Implementation
To find the most similar patches in the training library, we use the OPAL method 78 . OPAL is a fast approximate nearest neighbor patch search technique. This method enables to process each modality in about 4 seconds on a standard computer. The training library is equally composed of 37 images for both CN and AD subjects, leading to |T | = 76. The number of patches extracted from each the training library is K = 160 (i.e., 80 from CN subjects and 80 from AD patients) and the patch size is 5 × 5 × 5 voxels. Furthermore, as done in our PBG DTI study 57 , we used zero normalized sum of squared differences for T1w to compute the L2 norm (see Equation (2)). On the other hand, d-MRI is a quantitative imaging technique. Therefore, to preserve the quantitative information, a straight sum of squared differences is used for MD in Equation (2),
Validation
To evaluate the efficiency of each considered biomarker to detect AD alterations, CN group is compared to AD patients group. In addition, to discriminate the impairment severity of MCI group, eMCI versus lMCI classification is conducted. The classification step is performed with a linear discriminant analysis (LDA) within a repeated stratified 5-fold cross-validation 
Results
In this section, the results are presented in three parts. In the first part, we compare the different approach applied within the entire HIPP structure to evaluate the performance of our new MPBG compared to usual biomarkers such as volume and average MD. Afterwards, in the second part, we compare the accuracy of each considered biomarkers within hippocampal subfields to investigate the potential of hippocampal subfields analysis to improve result of AD detection and prediction. Finally, in a last part, we compare the results of our proposed multimodal biomarker with state-of-the-art methods based on d-MRI to show the competitive performance of our approach. 
Whole hippocampus
Results of the comparisons over the whole HIPP are represented in Table 2 . In this experiment, we compared the results of volume, mean of MD and PBG applied with both modality and MPBG over the whole hippocampus. First, the hippocampus volume and its average of MD were compared. For CN versus AD classification the volume obtains 86.6% of AUC and the average of MD obtains 80.6%. For eMCI versus lMCI classification the volume and the average of MD obtain 59.4% and 55.6% of AUC, respectively. Experiments demonstrate that the hippocampus the volume obtains better classification results than the average of MD for all comparison, especially for CN versus AD. Second, PBG biomarkers applied with T1w and MD were compared. The results showed that T1w PBG provides better results than MD PBG with 92.6% of AUC for CN versus AD classification. However, for eMCI versus lMCI classification MD grading provides the best results with 69.5% of AUC. MPBG methods combining both modalities reaches the best results for CN versus AD and eMCI versus lMCI with 92.1% and 69.5% of AUC, respectively. Finally, the proposed MPBG biomarker provides results similar to the best modalities for all considered comparisons. Compared to volume, MPBG improves CN versus AD comparison result by 5.5% of AUC and by over 10% of AUC for eMCI versus lMCI comparison. Thus, MBPG biomarker has a good capability to capture modifications caused by AD at different severity stages (see Figure 2) . Figure 4 shows the distribution of volumes (A), average of MD (B) and MPBG (C) for each hippocampal subfield at each different AD stages. For each comparison a p-value was estimated with a multi-comparison test 79 . We can note that for all hippocampal subfields, alterations caused by the disease are related to a volume and MPBG decrease with a MD increase. Subiculum subfield presents the most significant differences for several comparisons. More importantly, it is the only subfield providing a p-value inferior than 0.05 for the comparison CN versus eMCI with volume, a p-value inferior than 0.01 to lMCI versus AD with MD and a p-value inferior to 0.001 to eMCI versus lMCI with MPBG, which are the most challenging comparisons. The distribution of MPBG shows a better discrimination between each group for all hippocampal subfields. Indeed, MPBG applied within CA1SP, and CA1SR-L-M provides p-values inferior than 0.01 for eMCI versus lMCI. Moreover, MPBG applied within the subiculum provides p-value inferior than 0.001 for the same comparison. Thus, MPBG enables to perform a detection of AD with each subfield with an advantage for subiculum for the comparison of eMCI versus lMCI .
Hippocampal subfields
To estimate the efficiency of the considered biomarkers for AD detection, we also performed a classification experiment. Figures 5 shows the results of two comparisons, CN versus AD (part noted A in the figure) and eMCI versus lMCI (part noted B). First, for AD diagnosis (i.e., CN versus AD classification), the subfield providing the most discriminant volume is the CA1S-R-L-M with an AUC of 86.0%. Moreover, the most discriminant MD biomarker is given by the subiculum with an AUC of 88.1%. For this comparison, MD of subiculum is the only biomarker performing better results than whole hippocampus. The best results obtained by MPBG feature is provided by the CA1SP with an AUC of 92.1% followed by CA1S-R-L-M and subiculum. Second, for eMCI versus lMCI classification, the subiculum provides the best results for each considered feature. Indeed, subiculum obtained an AUC of 66.1% for the volume, 62.4% for the average of MD, and 71.8% for MPBG. Moreover, subiculum provided better results than whole hippocampus for each feature. Thus, the experiments conducted with three different biomarkers showed that the use of hippocampal subfields, especially the subiculum, enables to obtain better results for AD prediction than the whole hippocampal analysis. 
Comparison with state-of-the-art methods
To evaluate the performance of the proposed MPBG, we compared it with state-of-the-art multimodal methods using d-MRI. To this end, we used the ACC values published by the authors. Table 3 shows the comparison of our proposed biomarkers within the hippocampal area providing the best results (i.e. the whole HIPP and the subiculum) with the state-of-the-arts methods using similar dataset based on ADNI-2. We compared these biomarkers with a method using features based on tractography 80 , a method based on a connectivity network of the different brain structures 52 , and a voxel-based method that analyzes alterations of white matter 81 . The results of comparison show that MPBG over whole HIPP obtains the best score for AD versus CN with 88.1% of accuracy while the best result is achieved by a voxel-based method with a feature selection 81 that obtained 87.0% on similar ADNI2 dataset. For the best of our knowledge, the only work providing eMCI and lMCI comparison 52 using d-MRI from similar ADNI2 dataset is based on a connectivity network and obtained 63.4%. These comparisons demonstrate the relevance of MPBG biomarkers for AD detection and prediction. Indeed, our method provides similar results than the best methods with similar dataset for CN versus AD classification and provides the best results for eMCI versus lMCI classification. Moreover, the proposed MPBG method based on subiculum improves the performance for eMCI versus lMCI classification with an accuracy of 70.8%, that increases by 2% the accuracy based the whole HIPP and over 6% compared to a connectivity network based method.
Discussion
In this work, a multimodal analysis of the hippocampal subfields alterations caused by AD is proposed. First, the structural and micro-structural alterations were captured from two MRI modalities with different methods. Thus, the use of volume, MD, and the proposed MPBG methods were investigated to achieve this analysis. In this section, the efficiency of these different methods applied into the whole hippocampus and each hippocampal subfield are discussed.
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Whole hippocampus biomarkers We first compared the performance of different methods applied to the whole hippocampus (see Table 2 ). The experiments showed that volume and mean of MD within a structure as the hippocampus does not provides discriminant biomarkers to detect early stages of AD. The MPBG method based on s-MRI and d-MRI obtains best results compared to the volume and the average of MD. Moreover, compared to recent methods proposed for AD detection 82 (see Table 3 ), proposed MPBG demonstrates state-of-the-art performances for AD detection and prediction. These results emphasize the relevance of using more accurate biomarker, such MPBG to study the effectiveness of hippocampal subfields for AD detection and prediction.
Hippocampal subfield biomarkers
The main contribution of this study is the multimodal analysis of hippocampal subfields. Indeed, most of the proposed biomarkers based on hippocampus focused only on the whole structure or study alterations of hippocampal subfields with methods that do not provide sensitive biomarkers to detect early modification caused by AD. The lack of work studying alterations of hippocampal subfields with advanced biomarkers could be explained by the fact that automatic segmentation of the hippocampal subfields is a complex task due to subtle borders dividing each area.
In this work, we compared the efficiency of diffusion MRI and multimodal patch-based biomarkers for AD detection and prediction over the hippocampal subfields. Comparisons based on MD, volume and multimodal patch-based biomarkers showed that the subiculum is the most discriminant structure in the earliest stage of AD providing the best results for AD prediction (see Figure 4 and 5). However, whole hippocampus structure, followed by CA1SR-L-M, obtains best results for AD detection.
These results are in accordance with literature studies based on animal model and in vivo imaging combining volume and MD demonstrating that subiculum is the earliest hippocampal region affected by AD 42, 43 . Moreover, postmortem studies showed that the hippocampal degeneration in early stages of AD is not uniform. After the apparition of alterations in the EC, the pathology spreads to the subiculum, CA1, CA2-3 and finally the CA4 and DG subfields 36, 37, 42, 83 . It is interesting to note that the results of our experiments using volume-based biomarkers are also coherent with the previous in-vivo imaging studies that analyzed the atrophy of each hippocampal subfield at advanced stage of AD. These studies showed that CA1 is the subfield impacted by the strongest atrophy 38, 39, 84, 85 . Furthermore, studies using ultra-high field at 7T enabling CA1 layers discrimination showed that CA1SR-L-M is the subfields showing the greater atrophy at advanced stages of AD 40, 41 .
Conclusion
In this paper, we analyzed hippocampal subfield alterations with a multimodal framework based on structural and diffusion MRI. In addition, to study tenuous modifications occurring into each hippocampal subfield, we developed a new multimodal patch-based framework using T1w and DTI. Our novel MPBG method were compared to the volume and the average of MD over the whole hippocampus. This comparison demonstrated that MPBG method improves performances for AD detection and prediction. In addition, a comparison with state-of-the-art diffusion-based methods showed the competitive performance of MPBG biomarkers. Finally, an analysis of the hippocampal subfields with the volume, the average of MD and MBPG methods was conducted. Although CA1 is the subfields having the greater atrophy in the late stage of AD, the experiments demonstrated that whole hippocampus provides best biomarker for AD detection while subiculum provides best biomarker for AD prediction.
